LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

New Test Assesses Oxygen Delivering Ability of Red Blood Cells by Measuring Their Shape

By LabMedica International staff writers
Posted on 23 Dec 2024
Image: The new test could improve specialist transplant and transfusion practice as well as blood banking (Photo courtesy of NHS Blood and Transplant)
Image: The new test could improve specialist transplant and transfusion practice as well as blood banking (Photo courtesy of NHS Blood and Transplant)

The release of oxygen by red blood cells is a critical process for oxygenating the body's tissues, including organs and muscles, particularly in individuals receiving large blood transfusions. Healthy, fresh red blood cells have a characteristic biconcave shape, resembling a dumbbell, which facilitates efficient oxygen release. However, during refrigerated storage, red blood cells become energetically stressed and adopt a more spherical shape, slowing down their oxygen release. Researchers have now developed a method to assess the oxygen delivery capability of red blood cells by measuring their shape. This test could enhance practices in specialized transplant and transfusion settings, as well as improve blood banking procedures.

Researchers at the University of Oxford (Oxford, UK), in collaboration with NHS Blood and Transplant (London, UK), have created FlowScore, a formula designed to predict the rate at which red blood cells release oxygen. While earlier studies at Oxford's Department of Physiology, Anatomy, and Genetics identified factors affecting oxygen release from red cells, the testing method was too complex for routine use in blood centers focused on enhancing the monitoring of blood stored for transfusion. To adapt these findings for blood banking, NHS Blood and Transplant’s Component Development Laboratory joined the initiative, providing blood samples stored following NHS protocols and using measurements from hematology analyzers. These analyzers employ flow cytometry, which involves passing cells through a laser beam to examine their characteristics. The way light scatters off the cells reveals details about their size and shape.

The research, published in eBioMedicine, demonstrated that this information effectively predicts the oxygen release capacity of red blood cells, with the resulting predictive formula named FlowScore. This innovation simplifies, speeds up, and broadens access to red cell oxygen transport measurements for laboratories globally. Blood banks can now utilize FlowScore as a quality control tool during blood processing and storage. For instance, FlowScore helped quantify the positive effects of rejuvenating red blood cells and detect instances when blood handling deviated from blood bank standards. This could be crucial for monitoring the quality of stored blood in developing regions with higher ambient temperatures. Additionally, FlowScore may eventually offer a way to assess the quality of blood for specific patient groups if future research shows benefits for those populations.

“We find that FlowScore is a robust surrogate of oxygen-handling by red cells and provides new and important information on oxygen transport by the blood,” said Professor Pawel Swietach, Professor of Physiology at Oxford University. “Aside from its applications in transfusion medicine and blood banking, FlowScore can help identify new genetic, environmental and lifestyle factors that influence oxygen delivery to tissues.”

“FlowScore could become quite fundamental to the way blood is tested to ensure its quality,” added Dr. Peter Smethurst, from the NHSBT Blood and Transplant Component Development Laboratory. “It is a technical breakthrough that should improve the monitoring of stored blood and drive improvements that will most benefit vulnerable recipients of red cell transfusions.”

Related Links:
University of Oxford
NHS Blood and Transplant

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more